Chronic but not acute intracerebroventricular administration of amyloid β-peptide(25-35) decreases somatostatin content, adenylate cyclase activity, somatostatin-induced inhibition of adenylate cyclase activity, and adenylate cyclase I levels in the rat hippocampus

1. Burgos-Ramos, E.
2. Hervás-Aguilar, A.
3. Puebla-Jiménez, L.
4. Boyano-Adánez, M.C.
5. Arilla-Ferreiro, E.